Get started
Author

M. Crespo Casal

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
2021 · Anil Gupta, Yaneicy Gonzalez-Rojas, et al. · New England Journal of Medicine · 1,059
PDF
Gut Microbiota Linked to Sexual Preference and HIV Infection
2016 · Marc Noguera-Julian, Muntsa Rocafort, et al. · EBioMedicine · 445
PDF
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19
2022 · Anil Gupta, Yaneicy Gonzalez-Rojas, et al. · JAMA · 279
PDF
Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae
2018 · Adrian Sousa, María Teresa Pérez-Rodríguez, et al. · Journal of Antimicrobial Chemotherapy · 146
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
2015 · José R Arribas, Pierre-Marie Girard, et al. · The Lancet Infectious Diseases · 145
Pharmacokinetic Interaction Between Nevirapine and Rifampicin in HIV-Infected Patients With Tuberculosis
2001 · Esteban Ribera, Leonor Pou, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 145
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
2006 · Daniel Podzamczer, Elena Ferrer, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 137
Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study
2022 · Alexandre Pérez-González, Alejandro Araújo-Ameijeiras, et al. · Scientific Reports · 131
PDF
Cell Cycle Control and HIV-1 Susceptibility Are Linked by CDK6-Dependent CDK2 Phosphorylation of SAMHD1 in Myeloid and Lymphoid Cells
2014 · Eduardo Pauls, Alba Ruiz, et al. · The Journal of Immunology · 128
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine
2005 · Cesar Fisac, Emilio Fumero, et al. · AIDS · 116
Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients
2003 · A. Hidalgo, V. Falcó, et al. · European Radiology · 108
A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4 + T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients
2017 · Judith Grau-Expósito, Carla Serra-Peinado, et al. · mBio · 101
PDF
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques
2015 · Beatriz Mothe, Xintao Hu, et al. · Journal of Translational Medicine · 95
PDF
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection
2018 · Yolanda Guillén, Marc Noguera-Julian, et al. · Mucosal Immunology · 91
PDF
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
2021 · Onyema Ogbuagu, Peter J Ruane, et al. · The Lancet HIV · 89
Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection
2017 · Juan Berenguer, Elena Rodríguez‐Castellano, et al. · Hepatology · 67
PDF
Body composition changes after switching from protease inhibitors to raltegravir
2011 · Adrian Curran, Esteban Martinez, et al. · AIDS · 66
Peginterferon alpha‐2b plus ribavirin vs interferon alpha‐2b plus ribavirin for chronic hepatitis C in HIV‐coinfected patients
2006 · M. Crespo, S. Sauleda, et al. · Journal of Viral Hepatitis · 65
Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue
2017 · Sara Morón-López, Maria C. Puertas, et al. · PLoS ONE · 63
PDF
Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study
2020 · Sergio Serrano-Villar, Javier Martínez-Sanz, et al. · The Lancet HIV · 62
Improvements in Subcutaneous Fat, Lipid Profile, and Parameters of Mitochondrial Toxicity in Patients with Peripheral Lipoatrophy When Stavudine is Switched to Tenofovir (LIPOTEST Study)
2008 · Esteban Ribera, José Carlos Paradiñeiro, et al. · HIV Clinical Trials · 62
PDF
Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis
2007 · Esteban Ribera, Carlos Azuaje, et al. · Journal of Antimicrobial Chemotherapy · 59
PDF
Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells
2015 · Nicola Ternette, Hongbing Yang, et al. · European Journal of Immunology · 58
PDF
Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection
2014 · Mar Riveiro-Barciela, María Buti, et al. · PLoS ONE · 58
PDF
Steady-State Pharmacokinetics of a Double-Boosting Regimen of Saquinavir Soft Gel plus Lopinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Infected Adults
2004 · Esteban Ribera, Rosa M. Lopez, et al. · Antimicrobial Agents and Chemotherapy · 58
Works count: 10
Citation count: 25
H-index: 2
I10-index: 1
Year
Topic
Type